HYPERGLYCEMIC KIDNEY INFLAMMATION TREATING AGENT

摘要

The present invention describes pharmaceutical compositions for use in the treatment of diabetic nephropathy containing from 15 to 30 mg of N-(2-amino-3,5-dibromobenzyl)-N-methyl-cyclohexylamine and/or a physiologically compatible acid addition salt thereof as active ingredient, their method and their preparation.